标题
Clinical Trials in Rare Disease
作者
关键词
-
出版物
JOURNAL OF CHILD NEUROLOGY
Volume 28, Issue 9, Pages 1142-1150
出版商
SAGE Publications
发表日期
2013-09-06
DOI
10.1177/0883073813495959
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families
- (2012) C Malcolm et al. ACTA PAEDIATRICA
- Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis
- (2012) Shannon L. Macauley et al. ANNALS OF NEUROLOGY
- Mouse models of neuronal ceroid lipofuscinoses: Useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics
- (2012) John J. Shacka BRAIN RESEARCH BULLETIN
- The Rare Diseases Clinical Research Network Contact Registry update: Features and functionality
- (2012) Rachel L. Richesson et al. Contemporary Clinical Trials
- Orphan drug development: an economically viable strategy for biopharma R&D
- (2012) Kiran N. Meekings et al. DRUG DISCOVERY TODAY
- Rare diseases and orphan drugs
- (2012) Irena Melnikova NATURE REVIEWS DRUG DISCOVERY
- Emerging Subspecialties in Neurology: Fellowship in experimental therapeutics of neurologic disease
- (2012) J. M. Statland et al. NEUROLOGY
- Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease
- (2012) Attila D. Kovács et al. NEUROPHARMACOLOGY
- Enzyme replacement therapy for lysosomal storage diseases
- (2011) Robin H. Lachmann CURRENT OPINION IN PEDIATRICS
- Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses
- (2011) R. Kohan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The cost of drug development: A systematic review
- (2011) Steve Morgan et al. HEALTH POLICY
- Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses
- (2011) Maria Kousi et al. HUMAN MUTATION
- Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data
- (2011) Jennifer Cialone et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Females experience a more severe disease course in batten disease
- (2011) Jennifer Cialone et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients
- (2011) Chinmoy Sarkar et al. MOLECULAR GENETICS AND METABOLISM
- Quantitative telemedicine ratings in Batten disease: Implications for rare disease research
- (2011) J. Cialone et al. NEUROLOGY
- Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)
- (2011) J. R. Ostergaard et al. NEUROLOGY
- Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)
- (2011) J. M. Kwon et al. NEUROLOGY
- Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families
- (2011) Cari Malcolm et al. PALLIATIVE MEDICINE
- Antioxidant treatment in Spielmeyer-Sjögren's disease
- (2010) Pirkko Santavuori et al. ACTA NEUROLOGICA SCANDINAVICA
- Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009
- (2010) K I Kaitin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- JUVENILE NEURONAL CEROID LIPOFUSCINOSIS: DEVELOPMENTAL PROGRESS AFTER SUPPLEMENTATION WITH POLYUNSATURATED FATTY ACIDS
- (2010) Michael J. Bennett et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Research challenges in central nervous system manifestations of inborn errors of metabolism
- (2010) P.I. Dickson et al. MOLECULAR GENETICS AND METABOLISM
- The needs of the few
- (2010) NATURE
- Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease
- (2010) Attila D. Kovács et al. NEUROPHARMACOLOGY
- Pivotal studies of orphan drugs approved for neurological diseases
- (2009) Jun Mitsumoto et al. ANNALS OF NEUROLOGY
- Towards understanding the neuronal ceroid lipofuscinoses
- (2009) Alfried Kohlschütter et al. BRAIN & DEVELOPMENT
- Management of neuronopathic Gaucher disease: Revised recommendations
- (2009) A. Vellodi et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Challenges in the Search for Drugs to Treat Central Nervous System Disorders
- (2009) S. J. Enna et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dystonic storm due to Batten's disease treated with pallidotomy and deep brain stimulation
- (2009) Muruvet Elkay et al. MOVEMENT DISORDERS
- Neuronal ceroid lipofuscinoses
- (2008) Anu Jalanko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The transmembrane topology of Batten disease protein CLN3 determined by consensus computational prediction constrained by experimental data
- (2008) Timothy Nugent et al. FEBS LETTERS
- Clinical research for rare disease: Opportunities, challenges, and solutions
- (2008) Robert C. Griggs et al. MOLECULAR GENETICS AND METABOLISM
- Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis
- (2008) Michael Chang et al. MOLECULAR THERAPY
- INTERMITTENT PREDNISOLONE AND AUTOANTIBODIES TO GAD65 IN JUVENILE NEURONAL CEROID LIPOFUSCINOSIS
- (2008) L. Aberg et al. NEUROLOGY
- Adaptive design methods in clinical trials – a review
- (2008) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity
- (2007) Jian-Qiang Fan BIOLOGICAL CHEMISTRY
- Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease
- (2007) Attila D. Kovács et al. EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More